HK1218913A1 - 尼洛氫溴酸鹽,琥珀酸鹽,谷氨酸,乙酸, -蘋果酸與馬來酸鹽的晶體形式 - Google Patents
尼洛氫溴酸鹽,琥珀酸鹽,谷氨酸,乙酸, -蘋果酸與馬來酸鹽的晶體形式Info
- Publication number
- HK1218913A1 HK1218913A1 HK16106892.8A HK16106892A HK1218913A1 HK 1218913 A1 HK1218913 A1 HK 1218913A1 HK 16106892 A HK16106892 A HK 16106892A HK 1218913 A1 HK1218913 A1 HK 1218913A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- malate
- glutamate
- maleate
- succinate
- acetate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/25—Sulfonic acids having sulfo groups bound to carbon atoms of rings other than six-membered aromatic rings of a carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/29—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings
- C07C309/30—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings of six-membered aromatic rings substituted by alkyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/126—Acids containing more than four carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/06—Oxalic acid
- C07C55/07—Salts thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/08—Malonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/12—Glutaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/14—Adipic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/22—Tricarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/13—Dicarboxylic acids
- C07C57/15—Fumaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
- C07C59/48—Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C62/02—Saturated compounds containing hydroxy or O-metal groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Applications Claiming Priority (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35677110P | 2010-06-21 | 2010-06-21 | |
US35946910P | 2010-06-29 | 2010-06-29 | |
US36006410P | 2010-06-30 | 2010-06-30 | |
US36169110P | 2010-07-06 | 2010-07-06 | |
US36551010P | 2010-07-19 | 2010-07-19 | |
US37501310P | 2010-08-18 | 2010-08-18 | |
US37621310P | 2010-08-23 | 2010-08-23 | |
US38042810P | 2010-09-07 | 2010-09-07 | |
US38213610P | 2010-09-13 | 2010-09-13 | |
US38442810P | 2010-09-20 | 2010-09-20 | |
US39226610P | 2010-10-12 | 2010-10-12 | |
US40530110P | 2010-10-21 | 2010-10-21 | |
US41020210P | 2010-11-04 | 2010-11-04 | |
US201161434561P | 2011-01-20 | 2011-01-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1218913A1 true HK1218913A1 (zh) | 2017-03-17 |
Family
ID=44310310
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16106892.8A HK1218913A1 (zh) | 2010-06-21 | 2016-06-15 | 尼洛氫溴酸鹽,琥珀酸鹽,谷氨酸,乙酸, -蘋果酸與馬來酸鹽的晶體形式 |
Country Status (10)
Country | Link |
---|---|
US (2) | US8937082B2 (zh) |
EP (2) | EP2571863B1 (zh) |
JP (1) | JP5894153B2 (zh) |
KR (1) | KR20130042498A (zh) |
CA (1) | CA2803559A1 (zh) |
ES (1) | ES2555263T3 (zh) |
HK (1) | HK1218913A1 (zh) |
HR (1) | HRP20151324T1 (zh) |
PL (1) | PL2571863T3 (zh) |
WO (1) | WO2011163222A1 (zh) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN2010CH03577A (zh) * | 2010-11-26 | 2012-07-20 | Hetero Research Foundation | |
AR086913A1 (es) * | 2011-06-14 | 2014-01-29 | Novartis Ag | 4-metil-3-[[4-(3-piridinil)-2-pirimidinil]-amino]-n-[5-(4-metil-1h-imidazol-1-il)-3-(trifluoro-metil)-fenil]-benzamida amorfa, forma de dosificacion que la contiene y metodo para prepararlas |
ES2564969T3 (es) * | 2012-02-09 | 2016-03-30 | Natco Pharma Limited | Proceso para la preparación de clorhidrato de nilotinib |
US9061028B2 (en) | 2012-02-15 | 2015-06-23 | Natco Pharma Limited | Process for the preparation of Nilotinib |
AU2013332205B2 (en) * | 2012-10-15 | 2017-08-31 | Apotex Inc. | Solid forms of Nilotinib hydrochloride |
US9567317B2 (en) | 2012-10-19 | 2017-02-14 | Basf Se | Multicomponent crystalline system comprising nilotinib and selected co-crystal formers |
WO2014174456A2 (en) * | 2013-04-24 | 2014-10-30 | Dr. Reddys Laboratories Limited | Polymorphic forms of nilotinib hydrochloride |
WO2015092624A1 (en) | 2013-12-16 | 2015-06-25 | Ranbaxy Laboratories Limited | Nilotinib mono-oxalate and its crystalline form |
US9926296B2 (en) | 2014-08-08 | 2018-03-27 | Dr. Reddy's Laboratories Limited | Process for the preparation of polymorphic forms of nilotinib hydrochloride |
MX2017004770A (es) | 2014-10-16 | 2017-07-26 | Apotex Inc | Formas solidas del clorhidrato de nilotinib. |
CN106478603B (zh) * | 2015-08-25 | 2021-01-01 | 江苏豪森药业集团有限公司 | 尼洛替尼盐酸盐的新晶型及其制备方法和医药用途 |
SI3408264T1 (sl) | 2016-01-26 | 2020-07-31 | Farma Grs, D.O.O. | Nilotinibijev dinitrat (V) in njegove kristalne oblike |
SI3430004T1 (sl) | 2016-03-14 | 2021-03-31 | Pliva Hrvatska D.O.O. | Trdne oblike soli nilotiniba |
AU2017348665A1 (en) * | 2016-10-28 | 2019-05-02 | Apotex Inc. | Novel salts of nilotinib and crystalline forms thereof |
EP3404025B1 (en) | 2017-05-16 | 2019-12-04 | F.I.S.- Fabbrica Italiana Sintetici S.p.A. | Process for the preparation of pure nilotinib and its salt |
CZ2017821A3 (cs) | 2017-12-20 | 2019-07-03 | Zentiva, K.S. | Léková forma obsahující krystalický nilotinib |
TWI815137B (zh) | 2018-06-15 | 2023-09-11 | 漢達生技醫藥股份有限公司 | 尼洛替尼十二烷基硫酸鹽之結晶 |
WO2020095187A1 (en) * | 2018-11-05 | 2020-05-14 | Laurus Labs Limited | Crystalline form of nilotinib hydrochloride, process for its preparation and pharmaceutical composition containing the same |
US10874671B2 (en) | 2019-02-18 | 2020-12-29 | Slayback Pharma Llc | Pharmaceutical compositions of nilotinib |
US20230075170A1 (en) * | 2020-02-15 | 2023-03-09 | Cipla Limited | Novel salts of nilotinib and polymorphic forms thereof |
WO2023285981A1 (en) * | 2021-07-15 | 2023-01-19 | Torrent Pharmaceuticals Limited | Stable pharmaceutical liquid composition of nilotinib |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0215676D0 (en) * | 2002-07-05 | 2002-08-14 | Novartis Ag | Organic compounds |
GT200600315A (es) | 2005-07-20 | 2007-03-19 | Formas cristalinas de 4-metilo-n-[3-(4-metilo-imidazol-1-ilo)-5-trifluorometilo-fenilo]-3-(4-pyridina-3-ilo-pirimidina-2-iloamino)-benzamida | |
GT200600316A (es) * | 2005-07-20 | 2007-04-02 | Sales de 4-metilo-n-(3-(4-metilo-imidazol-1-ilo)-5-trifluorometilo-fenilo)-3-(4-piridina-3-ilo-pirimidina-2-iloamino)- benzamida. | |
HU227474B1 (en) | 2005-12-20 | 2011-07-28 | Richter Gedeon Nyrt | Process for industrial scale production of high purity donepezil hydrochloride polymorph i. |
ES2394258T3 (es) | 2008-11-05 | 2013-01-30 | Teva Pharmaceutical Industries Ltd. | Formas cristalinas de Nilotinib HCL |
WO2011033307A1 (en) | 2009-09-17 | 2011-03-24 | Generics [Uk] Limited | Nilotinib dihydrochloride salt |
-
2011
- 2011-06-21 CA CA2803559A patent/CA2803559A1/en not_active Abandoned
- 2011-06-21 ES ES11728501.5T patent/ES2555263T3/es active Active
- 2011-06-21 US US13/806,069 patent/US8937082B2/en active Active
- 2011-06-21 EP EP11728501.5A patent/EP2571863B1/en active Active
- 2011-06-21 WO PCT/US2011/041242 patent/WO2011163222A1/en active Application Filing
- 2011-06-21 KR KR1020127033454A patent/KR20130042498A/ko not_active Application Discontinuation
- 2011-06-21 PL PL11728501T patent/PL2571863T3/pl unknown
- 2011-06-21 JP JP2013516686A patent/JP5894153B2/ja not_active Expired - Fee Related
- 2011-06-21 EP EP15165125.4A patent/EP2966072A3/en not_active Withdrawn
-
2014
- 2014-11-12 US US14/538,939 patent/US9090598B2/en not_active Expired - Fee Related
-
2015
- 2015-12-04 HR HRP20151324TT patent/HRP20151324T1/hr unknown
-
2016
- 2016-06-15 HK HK16106892.8A patent/HK1218913A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
US20150099885A1 (en) | 2015-04-09 |
WO2011163222A1 (en) | 2011-12-29 |
ES2555263T3 (es) | 2015-12-30 |
US9090598B2 (en) | 2015-07-28 |
JP5894153B2 (ja) | 2016-03-23 |
CA2803559A1 (en) | 2011-12-29 |
EP2571863B1 (en) | 2015-09-23 |
US8937082B2 (en) | 2015-01-20 |
EP2966072A2 (en) | 2016-01-13 |
PL2571863T3 (pl) | 2016-03-31 |
KR20130042498A (ko) | 2013-04-26 |
EP2571863A1 (en) | 2013-03-27 |
EP2966072A3 (en) | 2016-02-24 |
US20130158059A1 (en) | 2013-06-20 |
HRP20151324T1 (hr) | 2016-01-29 |
JP2013529639A (ja) | 2013-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1218913A1 (zh) | 尼洛氫溴酸鹽,琥珀酸鹽,谷氨酸,乙酸, -蘋果酸與馬來酸鹽的晶體形式 | |
HK1181771A1 (zh) | 具有藥學活性的二取代三嗪衍生物 | |
HK1164050A1 (zh) | 取代的偶氮蒽衍生物、藥物組合物及其使用方法 | |
HK1208021A1 (zh) | 結晶和非結晶形式的托法替尼,以及包含托法替尼和滲透增強劑的藥物組合物 | |
HK1163450A1 (zh) | 氨基酯類衍生物及其鹽和使用方法 | |
LT2683708T (lt) | 3-(5-amino-2-metil-4-okso-4h-chinazolin-3-il)-piperidin-2,6-diono solidinės formos, jų farmacinės kompozicijos ir panaudojimas išradimo apibrėžtis | |
IL232598A0 (en) | Crystalline forms of vilzodone and vilzodone hydrochloride | |
EP2411009B8 (fr) | Applications thérapeutiques de dérivés de quinazolinedione | |
HK1200366A1 (zh) | -孕甾烯- β- -三醇- -二酮衍生物的藥物組合物和使用方法 | |
EP2451816A4 (en) | CRYSTALLINE FORM OF PRASUGREL HYDROBROMIDE AND PROCESS FOR PREPARING THE SAME | |
EP2562172A4 (en) | SPHAELACTON DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHOD FOR THE PRODUCTION AND THEIR USE | |
WO2011079193A3 (en) | Preparation of bendamustine and its salts | |
HK1165802A1 (zh) | 苯並噻嗪衍生物、其製備方法及其作為藥物的應用 | |
PL3210991T3 (pl) | Postać krystaliczna lewoizowalerylospiramycyny II oraz preparaty, sposoby wytwarzania i ich zastosowanie | |
IL215609A0 (en) | Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof | |
IL213177A0 (en) | Crystal forms, methods of preparation, pharmaceutical compositions and uses of nicousamide | |
EP2701504A4 (en) | Sulindac derivatives, their use and preparation | |
PL2474529T3 (pl) | Formy krystaliczne farmaceutycznej substancji czynnej | |
EP2386301A4 (en) | PHARMACEUTICAL COMPOSITION OF LEVOAMLOPIDINE OR PHARMACEUTICAL ACCEPTABLE SALTS AND BETA BLOCKERS, AND USE THEREOF | |
ZA201203631B (en) | New phenylhydrazone derivatives and their use as pharmaceuticals | |
IL220859A0 (en) | Alkyl-heterocycle-carbamate derivatives, their preparation and therapeutic application | |
TWM388885U (en) | Adjusting structure of chair back | |
PL387898A1 (pl) | Mebel przeksztalcalny, zwłaszcza do siedzenia i klękosiadu | |
ZA201303371B (en) | Crystalline pharmaceutically active ingredients | |
RS20100352A3 (en) | METHOD OF PREPARATION AND USE OF PHARMACOLOGICAL ACTIVE N-CARBAMYLMETHYL-4 (R) -Phenyl-2-Pyrrolidinone |